WHO PCV vaccination recommendations: 1p+1 dose schedules - Presentation slides

Pneumococcal disease is a leading cause of death and serious illness in young children, especially in low- and middle-income countries. Since 2007, WHO has recommended the introduction of PCV into routine infant immunization programmes globally. As a result of PCV introduction, the incidence of invasive pneumococcal disease has dramatically decreased over time. PCV prevents severe diseases like meningitis, pneumonia, and sepsis, as well as milder conditions like otitis media.

WHO has recently released an updated PCV Position Paper to reflect new evidence from recent studies and real-world use, which will help countries in optimizing PCV product, schedule, and/or strategy to improve vaccine coverage, reduce costs, and ultimately save more children's lives, especially in resource-limited settings. The Position Paper is available here: https://iris.who.int/server/api/core/bitstreams/2cce44bc-af0b-4103-9048-54353f7d7ba1/content

This webinar presented and discussed over aspects related to the 2-dose schedule recommendation (1p+1) that will be useful to immunization related staff.

The video recording of this webinar session is available in English and French.

Authors